TRACON Pharmaceuticals Inc (TCON)
1.82
-0.14
(-7.14%)
USD |
NASDAQ |
Apr 22, 16:00
1.81
-0.01
(-0.55%)
After-Hours: 20:00
TRACON Pharmaceuticals Cash from Operations (Quarterly): -0.522M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.522M |
| September 30, 2023 | 15.05M |
| June 30, 2023 | -5.851M |
| March 31, 2023 | -5.003M |
| December 31, 2022 | -4.653M |
| September 30, 2022 | -6.827M |
| June 30, 2022 | -8.017M |
| March 31, 2022 | -6.742M |
| December 31, 2021 | -5.114M |
| September 30, 2021 | -8.424M |
| June 30, 2021 | -4.174M |
| March 31, 2021 | -4.859M |
| December 31, 2020 | -3.626M |
| September 30, 2020 | -4.269M |
| June 30, 2020 | -3.855M |
| March 31, 2020 | -5.292M |
| December 31, 2019 | -4.243M |
| September 30, 2019 | -6.583M |
| June 30, 2019 | -5.773M |
| March 31, 2019 | -7.051M |
| Date | Value |
|---|---|
| December 31, 2018 | -8.126M |
| September 30, 2018 | -6.225M |
| June 30, 2018 | -10.18M |
| March 31, 2018 | -6.255M |
| December 31, 2017 | -2.309M |
| September 30, 2017 | 1.339M |
| June 30, 2017 | -4.708M |
| March 31, 2017 | -7.565M |
| December 31, 2016 | -5.985M |
| September 30, 2016 | -5.043M |
| June 30, 2016 | -9.454M |
| March 31, 2016 | -6.668M |
| December 31, 2015 | -7.518M |
| September 30, 2015 | -3.533M |
| June 30, 2015 | -3.312M |
| March 31, 2015 | -4.80M |
| December 31, 2014 | -3.167M |
| September 30, 2014 | -1.544M |
| June 30, 2014 | -1.61M |
| March 31, 2014 | 8.079M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-8.424M
Minimum
Sep 2021
15.05M
Maximum
Sep 2023
-4.146M
Average
-5.003M
Median
Mar 2023
Cash from Operations (Quarterly) Benchmarks
| BioSig Technologies Inc | -2.942M |
| Revolution Medicines Inc | -120.56M |
| Perspective Therapeutics Inc | -9.008M |
| Electromed Inc | 3.471M |
| Xtant Medical Holdings Inc | -0.915M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 1.324M |
| Free Cash Flow | 3.676M |
| Free Cash Flow Per Share (Quarterly) | -0.2637 |
| Free Cash Flow to Equity (Quarterly) | -0.522M |
| Free Cash Flow Yield | 123.4% |